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ABSTRACT
Objective: To assess the association of oxytocin
augmentation with obstetric anal sphincter injury
among nulliparous women.
Design: Population-based, case–control study.
Setting: Primary and secondary teaching hospital
serving a Norwegian region.
Population: 15 476 nulliparous women with
spontaneous start of labour, single cephalic
presentation and gestation ≥37 weeks delivering
vaginally between 1999 and 2012.
Methods: Based on the presence or absence of
oxytocin augmentation, episiotomy, operative vaginal
delivery and birth weight (<4000 vs ≥4000 g), we
modelled in logistic regression the best fit for
prediction of anal sphincter injury. Within the modified
model of main exposures, we tested for possible
confounding, and interactions between maternal age,
ethnicity, occiput posterior position and epidural
analgaesia.
Main outcome measure: Obstetric anal sphincter
injury.
Results: Oxytocin augmentation was associated with a
higher OR of obstetric anal sphincter injuries in women
giving spontaneous birth to infants weighing <4000 g
(OR 1.8; 95% CI 1.5 to 2.2). Episiotomy was not
associated with sphincter injuries in spontaneous
births, but with a lower OR in operative vaginal
deliveries. Spontaneous delivery of infants weighing
≥4000 g was associated with a threefold higher OR,
and epidural analgaesia was associated with a 30%
lower OR in comparison to no epidural analgaesia.
Conclusions: Oxytocin augmentation was associated
with a higher OR of obstetric anal sphincter injuries
during spontaneous deliveries of normal-size infants.
We observed a considerable effect modification
between the most important factors predicting anal
sphincter injuries in the active second stage of labour.
INTRODUCTION
Obstetric anal sphincter injuries occur in
0.5–5.0% of vaginal deliveries1 with a subse-
quently increased risk of faecal incontin-
ence.2–4 Nulliparity,1 3 5 high birth weight
(BW),1 3 5 6 operative vaginal delivery,1 3 5
advanced maternal age,1 5 6 Asian or African
ethnicity,1 7 and prolonged second stage of
labour3 7 8 are consistently reported as risk
factors for obstetric anal sphincter injuries,
whereas the effect of epidural analgaesia9 10
and episiotomy1 11–13 is debated. However,
only a few authors have evaluated oxytocin
augmentation as a possible risk factor for
obstetric anal sphincter injuries.5 14 15
Further, the current literature dealing with
risk factors for obstetric anal sphincter injur-
ies has not sufficiently addressed their pos-
sible interactions. Studies usually present a
summary of associations between risk factors
and obstetric anal sphincter injuries adjusted
for confounders without investigating effect
modification, that is, exploring whether the
effects are uniform across various levels of
the studied risk factors.
In many delivery units, oxytocin augmenta-
tion is used during more than half of
births.16 17 Oxytocin augmentation has been
shown to shorten the duration of labour, but
not to decrease the need for operative deliv-
eries.18 We hypothesise that oxytocin aug-
mentation may reduce control over
Strengths and limitations of this study
▪ Stratifying by the main risk factors that are active
during the expulsive phase of labour and testing
for confounders are strengths of the study.
▪ We reveal how oxytocin augmentation interacts
with the major factors active in the expulsive
phase of labour.
▪ The study is based on prospectively collected
data from a large, unselected population, which
makes bias unlikely.
▪ The study design is a limitation, as we cannot
prove causality between oxytocin augmentation
and obstetric anal sphincter injuries in an obser-
vational study.
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contractions and impair perineal support by causing the
delivery to progress too quickly, and thereby increase the
risk of perineal injury. Thus, the widespread use of oxy-
tocin in daily obstetric practice calls for an exploration
of its possible harmful effects. The aim of our study was
to assess the association between oxytocin augmentation
and obstetric anal sphincter injuries in a dynamic model
related to the active second stage of labour.
MATERIALS AND METHODS
The Department of Obstetrics and Gynecology of
Stavanger University Hospital serves as the only delivery
unit for a population of 320 000 people, and approxi-
mately 4500 deliveries occur there annually. From 1996
onward, all obstetric data have been consecutively
recorded. The electronic database consists of clearly
defined variables, and is continuously maintained using
standardised procedures for data entry and quality
control. During the study period, 15 May 1999 to 15 May
2012, 56 517 women with a pregnancy duration of
≥23 weeks of gestation delivered infants with a BW of
>300 g in the department. Estimated day of delivery was
determined by second trimester ultrasound scan or
from menstrual data when no ultrasound examination
was performed. We restricted the study population to
nulliparous women whose labour started spontaneously,
with single cephalic presentation, pregnancies of
≥37 weeks of gestation (Group 1 in Robson’s Ten Group
Classification System; TGCS19) and who delivered vagi-
nally. After excluding 69 women with missing data (52
without an estimated day of delivery, 17 with missing
information of fetal presentation at delivery), this case–
control study comprised 15 476 women.
The main outcome measure was obstetric anal sphinc-
ter injuries as defined by the International Continence
Society, that is, partial or complete tears of the anal
sphincter muscles, with or without disruption of the
anal mucosa (grades 3–4 perineal tears).20 When an
obstetric anal sphincter injury was suspected, the obstet-
rician on call diagnosed the grade of the tear during
surgical repair.
Oxytocin augmentation was defined as oxytocin used
to stimulate contractions during established labour. An
intravenous infusion of 5 international units (0.01 mg)
of oxytocin in 500 mL saline was administered, starting
with 30 mL/h and a dose increment of 15 mL/h every
15 min to a maximum of 180 mL/h, guided by the
response. Normal births were taken care of by midwives,
while doctors performed the operative deliveries.
Throughout the study period, episiotomy was performed
either mediolaterally or laterally. According to our rou-
tines and national guidelines, operative vaginal delivery
was indicated if delivery had not taken place after
60 min of bearing down. We used vacuum extraction
with a Malmström metal cup as the preferred procedure
for operative vaginal delivery. Vacuum extraction was
applied for mid-cavity and outlet release. A combination
of low-dose ropivicaine/fentanyl was used for epidural
analgaesia. Ethnicity was classified as Western, that is,
originating from Europe or North America, or
non-Western.
The intention of this study was to explore the effect of
three obstetric practices (oxytocin augmentation (O),
episiotomy (E) and vacuum/forceps (VF)) and BW on
obstetric anal sphincter injuries before other risk factors
were considered. These main risk factors correlate as
episiotomy is often used for instrumental deliveries and
when large babies are expected. Furthermore, oxytocin
augmentation is provided for failure to progress because
of dystocia. Women with dystocia are more often deliv-
ered instrumentally than women without dystocia. This
basic understanding of the birth dynamics of the first
and second stages of labour indicates that the main risk
factors may have a direct or indirect effect on obstetric
anal sphincter injuries, and that the effects of categories
across different explanatory variables are not constant
on the outcome.
We analysed our dataset using the χ2 test and back-
ward manual stepwise logistic regression analyses with
p<0.05 as significance level. We built and checked the fit
of our regression model as proposed by Agresti.21 Step
one compares the model including the highest order
four-way interaction with a model without the four-way
interaction. If the highest order product is not signifi-
cant, Agresti proposes continuing by removing the
highest order term with the highest non-significant p
value until all remaining terms have statistically signifi-
cant p values. Four main predictors (O, E, VF and BW)
are used to predict the proportions of women with
sphincter injuries. Confounders, possible risk factors in
addition to the main factors of interest, were tested one
by one and set to at least 10% change in any estimate in
the model of best fit. Interaction terms were significant
at p<0.05. Statistical analyses were performed with IBM
SPSS Statistics for Windows, V.19.0, IBM Corp, Armonk,
New York, USA.
The Regional Committee for Medical and Health
Research Ethics, Western Norway, approved the protocol
as a quality assurance study in obstetric care, and fulfill-
ing the requirements for data protection procedures
(REK 2011-1247).
RESULTS
The study population comprised 15 476 (27%) of the
56 517 women giving birth during the study period,
including 1013 (53%) of a total of 1894 women diag-
nosed with obstetric anal sphincter injuries.
The overall prevalence of obstetric anal sphincter
injuries was 6.5%. The rate declined from 9.6% in 1999–
2000 to 2.8% in 2010–2012. The characteristics of the
study population and the prevalence of obstetric anal
sphincter injuries are displayed in table 1.
The prevalence was higher in women who received oxyto-
cin augmentation (8.0% vs 5.3%), those who were delivered
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instrumentally (11.0% vs 5.2%) and in those who gave birth
to an infant weighing ≥4000 g (12.9% vs 5.6%).
Furthermore, the prevalence increased with longer dura-
tions of the active part of the second stage of labour.
After adopting the strategy of Agresti by deleting the
highest statistically non-significant terms in the model
until all remaining terms are statistically significant, we
ended up with a best fitting model involving the three-
way interaction of oxytocin augmentation, episiotomy
and vacuum/forceps (O×E×VF) and the two two-way
interactions episiotomy/birth weight (E×BW) and
vacuum/forceps (VF×BW) (model A). We could resolve
interaction terms into stratified analysis of eight strata of
combinations of oxytocin augmentation, episiotomy and
instrumental delivery for BW <4000 g, and four strata of
combinations of episiotomy, instrumental delivery and
BW ≥4000 g, independent of oxytocin augmentation.
The results are displayed in table 2.






Per cent p ValueFactor
No Yes
N=14 463 N=1013
Per cent Per cent
Time period <0.001
1999–2000 11.1 16.9 1781 9.6
2001–2003 19.8 30.7 3169 9.8
2004–2006 22.9 29.6 3611 8.3
2007–2009 25.5 14.3 3826 3.8
2010–2012 20.8 8.6 3089 2.8
Maternal factors
Age (years) <0.001
<25 26.6 19.3 4040 4.9
25–29 33.5 37.6 5233 7.3
30–34 17.8 20.8 2785 7.6
≥35 22.1 22.2 3418 6.6
Origin NS*
Western 90.5 92.0 14 025 6.6
Non-Western 9.5 8.0 1451 5.6
Obstetric factors
Epidural analgaesia NS
No 58.1 57.7 8992 6.5
Yes 41.9 42.3 6484 6.6
Oxytocin augmentation <0.001
No 55.6 44.7 8500 5.3
Yes 44.4 55.3 6976 8.0
Active 2nd stage of labour (min) <0.001
Missing information 0.6 0.3 92 3.3
0–14 10.8 6.8 1627 4.2
15–29 26.8 18.5 4063 4.6
30–59 40.1 37.8 6181 6.2
≥60 21.7 36.6 3513 10.6
Episiotomy NS
No 67.1 65.4 10 372 6.4
Yes 32.9 34.6 5104 6.9
Operative vaginal delivery <0.001
No 77.5 60.3 11 817 5.2
Yes 22.5 39.7 3659 11.0
Fetal factors
Birth weight (g) <0.001
<4000 87.8 74.2 13 454 5.6
≥4000 12.2 25.8 2022 12.9
Occiput posterior position NS
No 95.4 94.8 14 771 6.5
Yes 4.5 5.2 705 7.4
p Values from χ2 tests.
*Non-significant.
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From a clinical perspective we can simplify model A
into model B by collapsing groups that comprise similar
risks for sphincter injury by obstetric interventions
despite overlapping CIs. Spontaneous delivery of an
infant weighing <4000 g without oxytocin augmentation
and episiotomy was chosen as the reference group
(group 1). We collapsed groups 1 and 2 as the OR for
sphincter injury was similar with and without episiotomy
in unstimulated, spontaneous births of normal-size
infants. Groups 3 to 6 displayed the OR for sphincter
injury in instrumental deliveries of normal-size infants
with and without oxytocin augmentation and episiotomy.
A marked difference in the OR for sphincter injury was
observed between women delivered instrumentally with
(groups 3 and 5) and without (groups 4 and 6) episiot-
omy, despite the fact that those stimulated with oxytocin
had a non-significant lower OR for sphincter injury. It
was, therefore, reasonable to collapse groups 3 and 5
and groups 4 and 6. Furthermore, we collapsed groups 7
and 8 as the OR for sphincter injury was similar with
and without episiotomy during spontaneous deliveries of
infants <4000 g, regardless of oxytocin augmentation.
Finally, the use of episiotomy appeared to be strongly
associated with lower OR for sphincter injury in instru-
mental deliveries of infants ≥4000 g (groups 11 and 12).
The modified model B (table 3) comprises a clinically
relevant risk estimation of anal sphincter injury among
the main modified risk factors for sphincter injury.
Age, origin of the mother and occiput posterior pos-
ition had no confounding effect on ORs for obstetric
anal sphincter injury across combinations of episiotomy,
oxytocin augmentation, operative vaginal delivery and
BW (groups A to G in table 3).
The unadjusted OR for the presence or absence of
epidural analgaesia was 1.02; however, the adjusted OR
for epidural analgaesia was 0.73, (95% CI 0.63 to 0.84),
that is, epidural analgaesia was associated with a 30%
lower OR of anal sphincter injury.
Table 2 Model A: Stratified analyses of eight strata of combinations of oxytocin augmentation, episiotomy, instrumental
delivery and birth weights <4000 g, and four strata of episiotomy, instrumental delivery and birth weights ≥4000 g,











N (%) OR 95% CI
1 − − − − 5328 198 (3.7) 1.0
2 − + − − 1434 60 (4.2) 1.1 0.8 to 1.5
3 − + + − 537 43 (8.0) 2.3 1.6 to 3.2
4 − − + − 316 47 (14.9) 4.5 3.2 to 6.4
5 + + + − 1283 92 (7.2) 2.0 1.6 to 2.6
6 + − + − 896 103 (11.5) 3.4 2.6 to 4.3
7 + − − − 2621 148 (5.6) 1.6 1.3 to 1.9
8 + + − − 1039 61 (5.9) 1.6 1.2 to 2.2
9 +/– + − + 418 40 (9.6) 2.7 1.9 to 3.9
10 +/− − − + 977 104 (10.6) 3.1 2.4 to 4.0
11 +/− + + + 393 55 (14.0) 4.2 3.1 to 5.8
12 +/− − + + 234 62 (26.5) 9.3 6.8 to 12.9
Crude OR and 95% CIs.
*Used (+)/unused (−).
†≥4000 g (+)/<4000 g (−).
‡Obstetric anal sphincter injury.














N (%) OR aOR (95% CI)
A (1,2) − +/− − − 6762 258 (3.8) 1.0 1.0
B (7,8) + +/− − − 3660 209 (5.7) 1.5 1.8 (1.5 to 2.2)
C (3,5) +/− + + − 1820 135 (7.4) 2.0 2.3 (1.8 to 2.8)
D (4,6) +/− − + − 1212 150 (12.4) 3.6 4.1 (3.3 to 5.1)
E (9–10) +/− +/− − + 1395 144 (10.3) 2.9 3.1 (2.5 to 3.9)
F (11) +/− + + + 393 55 (14.0) 4.1 4.7 (3.4 to 6.5)
G (12) +/− − + + 234 62 (26.5) 9.1 10.5 (7.6 to 14.4)
Unadjusted OR, adjusted (aOR) and 95% CIs after adjusting for epidural analgaesia.
*Used (+)/unused (−).
†≥4000 g (+)/<4000 g (−).
‡Obstetric anal sphincter injury.
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The use of oxytocin augmentation increased with the
duration of the second stage of labour over all the time
periods from an average of 32% in the <30 min group,
46% in the 30–59 min group, and 65% (range 49–76%)
in the ≥60 min group during the active second stage of
labour. The prevalence of operative deliveries across all
study periods was consistently between 45% and 49%
when the active part of the second stage of labour lasted
≥60 min versus 12–21% for durations of the second
stage of labour of <60 min. We found strong associations
between oxytocin augmentation and the duration of the
second stage, and between operative delivery and the
duration of the second stage (collinearity), which means
that the duration of the second stage is measured
through operative delivery and oxytocin augmentation.
DISCUSSION
We found that oxytocin augmentation during active
labour was associated with a 80% increased OR of
obstetric anal sphincter injury in women in TGCS group
1 giving spontaneous birth to an infant weighing
<4000 g. We did not find an association between episiot-
omy and tears during spontaneous deliveries, but a sig-
nificantly reduced association in all operative vaginal
deliveries.
Oxytocin augmentation is widely used in delayed
labour to prevent operative delivery. However, a
Cochrane review concluded that a reduction of labour
by 2 h was the only proven effect, and there was no
effect on operative deliveries.18 Another recent review
found the entire concept of active management of
labour to be associated with a slightly reduced risk of
caesarean delivery.22 As in other studies, we found that
approximately 50% of nulliparous women received oxy-
tocin augmentation.16 17 23 There is reason to believe
that guidelines for the diagnosis and treatment of pro-
tracted labour are unclear or inconsistently applied in
daily practice.17 We hypothesise that stimulation with
oxytocin may speed up the progress of the expulsive
phase of labour leading to rushed situations, impaired
communication with the mother, less focus on protec-
tion of the perineum and a controlled delivery of the
head. Recent studies from Norway indicate that focus on
these elements is important in preventing perineal
injuries.24 25
Many authors have used logistic regression analysis to
identify risk factors for obstetric anal sphincter injuries,
but only a few have included oxytocin augmentation.
Samuelsson et al,14 Prager et al,15 and Jander and
Lyrenas5 found oxytocin augmentation to be predictive
of obstetric anal sphincter injuries in univariate analysis,
but only Jander and Lyrenas confirmed this finding in
multivariable analyses. Samuelsson et al14 did not stratify
by parity, which is a methodological weakness since the
true effect of other factors is concealed by the strong
impact of parity. Prager et al15 studied obstetric anal
sphincter injuries in nulliparous women, entering
oxytocin augmentation, duration of active second stage
of labour and instrumental delivery into the same
model.
Our study shows strong collinearity between a pro-
longed active second stage of labour and both oxytocin
augmentation and instrumental delivery. We consider
the duration of the active second stage of labour to be a
‘proxy’ for oxytocin augmentation and instrumental
delivery, and not a risk factor for obstetric anal sphincter
injury in itself. Long duration of the second stage is a
time-related event before the expulsion of the head.
During this latency the active forces do not inflict injury
on the sphincter apparatus, the sphincter injury occurs
during the expulsive phase. Consequently, we do not
consider the duration of the active second stage as a risk
factor for anal sphincter injuries.
Jander and Lyrenas5 conducted a single institution,
retrospective, case–control study of 214 cases to explore
44 possible risk factors, and found that oxytocin aug-
mentation was a significant risk factor for obstetric anal
sphincter injuries in multivariable analyses (OR 2.00;
95% CI 1.13 to 3.53). However, these researchers did
not stratify by parity or state whether or not interactions
were tested for. Furthermore, three older studies on the
risk of obstetric anal sphincter injury included oxytocin
use without differentiating whether oxytocin was pro-
vided for induction or augmentation purposes.26–28
Three large population-based studies on the risk of
obstetric anal sphincter injuries did not include oxytocin
augmentation in their analyses.1 7 8
The influence of epidural analgaesia on anal sphinc-
ter injuries is unclear. Eskandar and Shet9 found a
reduced risk, but did not stratify by parity. Dahl and
Kjølhede10 found epidural analgaesia to be an inde-
pendent protective factor in nulliparous women. Poen
et al29 stratified by parity and found a significantly
increased OR associated with epidural analgaesia in nul-
liparous women. In our study, epidural analgaesia was
associated with a significantly reduced OR for sphincter
tears.
Our study takes into account four factors that exert
their effect on the anal sphincter during the final
minutes of delivery. As in previous studies,1 3 5 we found
both operative vaginal delivery and high BW to be
strongly associated with obstetric anal sphincter injuries.
We found episiotomy to be associated with a lower preva-
lence of sphincter tears in operative vaginal deliveries,
but not in spontaneous births. This is consistent with a
large national registry study from Norway,1 but differs
from other studies.8 11 13 30 31 In our study, neither oxy-
tocin augmentation nor episiotomy were associated with
obstetric anal sphincter injury during spontaneous deliv-
ery of an infant weighing ≥4000 g.
Our methodological approach, stratifying by the
factors that are active during the expulsive phase of
labour and testing for confounders, is considered the
strength of the study. This approach leads to a more
detailed understanding of how oxytocin augmentation
Rygh AB, et al. BMJ Open 2014;4:e004592. doi:10.1136/bmjopen-2013-004592 5
Open Access
group.bmj.com on December 29, 2014 - Published by http://bmjopen.bmj.com/Downloaded from 
interacts with these major risk factors. Logistic regression
analyses, without testing for possible interactions, would
fail to reveal this information. This case–control study is
based on prospectively collected data from a large unse-
lected population, and represents all deliveries meeting
the inclusion criteria that occurred during the study
period, which make bias unlikely. Our department has a
high proportion of vaginal deliveries. The overall caesar-
ean delivery rate in our institution was 12.5% over the
study period. For women in TGCS group 1 the acute
caesarean section rate increased from 5.0% in 1999 to
7.5% in 2012. Accordingly, the study population includes
both high-risk and low-risk pregnancies, which adds to
the external validity of our results.
However, some limitations apply. We cannot prove caus-
ality between oxytocin augmentation and obstetric anal
sphincter injuries in an observational study. Furthermore,
socioeconomic status, smoking, body mass index, mater-
nal delivery positions, perineal support technique and
the birth attendant’s experience level may be possible
risk modifiers not included in our database. Finally,
single institution studies, also when based on unselected
populations, should be interpreted with caution.
Our findings have some important implications. Birth
attendants should be aware of the association between
oxytocin augmentation and obstetric anal sphincter
injuries in the large subgroup of nulliparous women
giving spontaneous birth to a normal-size infant. More
restrictive use of oxytocin may help prevent obstetric
anal sphincter injuries. Implementation of evidence-
based guidelines for using oxytocin augmentation
should be encouraged. The WHO recommends the use
of a partogram with an action line defining failure to
progress. However, a recent Cochrane review could not
confirm that such a partogram was beneficial in high
resource settings.32 Given the doubtful benefits from
augmentation of labour, randomised controlled trials
are strongly needed, and we propose anal sphincter
injury as one of the most important endpoints.
Moreover, our study supports restricted use of episiot-
omy during normal births and as a recommendation for
operative vaginal deliveries. BW is an important, albeit
unpredictable risk factor as weight estimation of a large
fetus is unreliable.33
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